Woburn, MA, United States of America

Eukarion, Inc.

Calculating rank
USPTO Granted Patents = 14

% Expired Patents = 28.6

Forward Citations = 246

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Bernard Malfroy-Camine (10 out of 15 patents)

silverMedal Susan Robin Doctrow (9 out of 10 patents)

bronzeMedal Bernard Meunier (2 out of 15 patents)

4.  Ann Louise Walker (2 out of 2 patents)

5.  George Edward Tranter (2 out of 2 patents)

6.  Gerard Martin Paul Giblin (2 out of 2 patents)

7.  Philip Charles Box (2 out of 3 patents)

8.  Ian B Campbell (2 out of 23 patents)

9.  Frédéric Cosledan (1 out of 2 patents)

10.  Frédéric Cosledan (1 out of 1 patent)

11.  Michel Baudry (1 out of 1 patent)


14 patents:

Company Overview
Eukarion, Inc. is a biotechnology company based in Woburn, Massachusetts, specializing in the development of innovative therapeutics aimed at addressing various diseases. The organization focuses on harnessing advanced scientific research to create solutions that enhance cellular health and combat oxidative stress. Eukarion's expertise lies in the fields of drug discovery and development, with a commitment to translating scientific advancements into effective treatments for patients, thereby contributing to the broader healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

14 Patents

#51 in Woburn, MA

#1,364 in Massachusetts

#22,344 in US

#42,312 in the World

Woburn, MA (US)
Woburn, MA, United States of America
Forward Citations = 246

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Eukarion, Inc.. Retrieved from https://idiyas.com/company/eukarion

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…